Rigerna Therapeutics
PrivateLast Round
Early Funding
Apr 2, 2026
Total Funding Raised
$60M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rigerna Therapeutics is a biotechnology company that develops nucleic acid drugs and siRNA therapies intended to treat liver and non-liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rigerna Therapeutics Comparables
Compare Rigerna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rona Therapeutics | 88% | |
| Borealis Biosciences | 84% | |
| Argo Biopharma | 83% |
Rigerna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 2, 2026 | ||||
| Seed | Oct 1, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 327% MoM.
- Apr 2, 2026
$30M raised in early funding.
Rigerna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rigerna Therapeutics's valuation, stock price, and market status.
Is Rigerna Therapeutics a public or private company?
Rigerna Therapeutics is a private company.
What is the current stock price of Rigerna Therapeutics?
Rigerna Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Rigerna Therapeutics worth (valuation)?
Valuation information for Rigerna Therapeutics is not publicly available.
Can I buy Rigerna Therapeutics stock?
Rigerna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rigerna Therapeutics's last funding round?
Rigerna Therapeutics's most recent funding round was Early Funding on April 2, 2026.
Who are the main investors in Rigerna Therapeutics?
Investor information for Rigerna Therapeutics is not publicly disclosed.
Will Rigerna Therapeutics IPO soon?
No public IPO plans have been announced for Rigerna Therapeutics.
How can I track Rigerna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rigerna Therapeutics's secondary market activity and sign up for updates.